Jean Francois Formela's Net Worth
$278 Million
Who is Jean Francois Formela?
Jean Francois Formela has an estimated net worth of $278 Million. This is based on reported shares across multiple companies, which include HORIZON PHARMA, INC., EXELIXIS INC, Intellia Therapeutics, Inc., Spero Therapeutics, Inc., Ikena Oncology, Inc., Translate Bio, Inc., Egalet Corp, ARCA biopharma, Inc., ACHILLION PHARMACEUTICALS INC, NxStage Medical, Inc., SGX PHARMACEUTICALS, INC., Korro Bio, Inc., and DECODE GENETICS INC.
SEC CIK
Jean Francois Formela's CIK is 0001030575
Past Insider Trading and Trends
2021 was Jean Francois Formela's most active year for acquiring shares with 9 total transactions. Jean Francois Formela's most active month to acquire stocks was the month of January. 2003 was Jean Francois Formela's most active year for disposing of shares, totalling 74 transactions. Jean Francois Formela's most active month to dispose stocks was the month of August. 2020 saw Jean Francois Formela paying a total of $7,534,988.63 for 5,413,696 shares, this is the most they've acquired in one year. In 2021 Jean Francois Formela cashed out on 37,766,360 shares for a total of $229,684,202.52, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
HORIZON PHARMA, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +28.97% | 828.44K |
$3.62 | $2,999,957.79 | 3.69M |
Mar 2
| |||
Form 4
|
∞
| 2.53M |
$9.00 |
—
| 2.53M |
Aug 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
EXELIXIS INC (EXEL) Snapshot price: $20.24
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -31.99% | -275.00K |
$7.78 | -$2,138,990.00 | 584.52K |
Sep 6 - Sep 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 23
| |||
Form 4
| -19.89% | -200.00K |
$6.80 | -$1,360,000.00 | 805.47K |
Aug 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 9
| |||
Form 4
| -0.44% | -4.40K |
$6.64 | -$29,230.08 | 1.01M |
Dec 5
| |||
Form 4
| -1.98% | -20.40K |
$7.00 | -$142,759.20 | 1.01M |
Dec 3
| |||
Form 4
| -8.03% | -90.00K |
$6.99 | -$628,758.00 | 1.03M |
Dec 2
| |||
Form 4
| -21.67% | -310.00K |
$6.64 | -$2,059,547.00 | 1.12M |
Dec 1
| |||
Form 4
| -6.53% | -100.00K |
$6.58 | -$658,160.00 | 1.43M |
Nov 28
| |||
Form 4
| -1.60% | -24.90K |
$6.50 | -$161,947.11 | 1.53M |
Nov 26
| |||
Form 4
| -2.37% | -37.70K |
$6.73 | -$253,566.43 | 1.56M |
Nov 25
| |||
Form 4
| -6.46% | -110.00K |
$6.40 | -$704,462.00 | 1.59M |
Nov 24
| |||
Form 4
| -0.73% | -12.50K |
$6.36 | -$79,502.50 | 1.7M |
Nov 21
| |||
Form 4
| -0.15% | -2.50K |
$6.50 | -$16,250.00 | 1.72M |
Nov 20
| |||
Form 4
| -0.87% | -15.00K |
$7.10 | -$106,497.00 | 1.72M |
Nov 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Intellia Therapeutics, Inc. (NTLA) Snapshot price: $26.14
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +248.19% | 5.2K |
—
|
—
| 7.29K |
Jun 14
| |||
Form 4
| -98.22% | -553.38K |
$132.73 | -$73,448,878.91 | 10K |
Scheduled
|
Jun 28
| ||
Form 4
|
∞
| 2.09K |
—
|
—
| 2.09K |
Jun 23
| |||
Form 4
| -15.18% | -201.72K |
$88.15 | -$17,558,773.95 | 1.13M |
Scheduled
|
Jun 11 - Jun 14
| ||
Form 4
| -0.59% | -4.51K |
$85.43 | -$385,545.59 | 765.1K |
Scheduled
|
Apr 29
| ||
Form 4
| -30.83% | -342.96K |
$85.96 | -$29,482,338.40 | 769.61K |
Scheduled
|
Apr 26 - Apr 28
| ||
Form 4
| -0.07% | -800.00 |
$84.98 | -$67,984.00 | 1.11M |
Scheduled
|
Apr 5
| ||
Form 4
| -31.07% | -501.94K |
$60.29 | -$30,262,715.80 | 1.11M |
Feb 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 4
| -100.00% | -6.69K |
$31.17 | -$208,397.27 |
0
|
Scheduled
|
Jul 16
| ||
Form 4
| -100.00% | -6.69K |
$27.96 | -$186,908.24 |
0
|
Scheduled
|
Jun 19
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
| -100.00% | -6.69K |
$25.04 | -$167,389.36 |
0
|
Scheduled
|
May 16
| ||
Form 4
| -100.00% | -39.24K |
$23.87 | -$936,742.63 |
0
|
Mar 20
| |||
Form 4
| -4.02% | -150.00K |
$16.24 | -$2,435,440.00 | 3.58M |
Jul 7 - Jul 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
| -100.00% | -21.13K |
$13.91 | -$293,842.63 |
0
|
Mar 9 - Mar 10
| |||
Form 4
|
∞
| 4.43M |
—
|
—
| 4.43M |
May 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Spero Therapeutics, Inc. (SPRO) Snapshot price: $1.43
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
| +5,528.97% | 2.37M |
$14.00 |
—
| 2.41M |
Nov 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Ikena Oncology, Inc. (IKNA) Snapshot price: $1.39
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 21
| |||
Form 4
| +4.89% | 98.72K |
$15.34 | $1,614,428.13 | 2.12M |
Mar 30 - Dec 14
| |||
Form 4
| +2,809.29% | 4.75M |
—
|
—
| 4.92M |
Dec 21 - Mar 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||